EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multicenter evaluation of broth microdilution method for susceptibility testing of Cryptococcus neoformans against fluconazole



Multicenter evaluation of broth microdilution method for susceptibility testing of Cryptococcus neoformans against fluconazole



Journal of Clinical Microbiology 34(5): 1280-1282



We have developed a microdilution method for measuring the susceptibility of Cryptococcus neoformans to fluconazole. The present study evaluated the interlaboratory agreement of the results for the microdilution method obtained at three different sites and compared this method with the National Committee for Clinical Laboratory Standards M27-P reference method. Excellent interlaboratory agreement among the results obtained at the three sites was achieved With this method (83 and 96% agreement within 1 and 2 log-2 dilutions, respectively). An overall agreement of 90% between the microdilution method and the M27-P method was observed, demonstrating the comparability of the two methods. However, there are inherent problems with the M27-P method in relation to measuring C. neoformans susceptibility, including suboptimal growth of the organism in RPMI 1640, a longer incubation period, and a narrow range of MICs. On the basis of these data, the microdilution method tested in this study is recommended for inclusion in the National Committee for Laboratory Standards method for testing the antifungal susceptibility of C. neoformans.

(PDF emailed within 1 workday: $29.90)

Accession: 002900844

Download citation: RISBibTeXText

PMID: 8727919



Related references

Fluconazole susceptibility testing of Cryptococcus neoformans: comparison of two broth microdilution methods and clinical correlates among isolates from Ugandan AIDS patients. Journal of Clinical Microbiology 36(10): 2874-2876, 1998

Comparison of broth macrodilution, broth microdilution and E-test susceptibility tests of Cryptococcus neoformans for fluconazole. Mycoses 40(11-12): 423-427, 1998

Susceptibility testing of Cryptococcus neoformans using the urea broth microdilution method. Mycoses 41(1-2): 41-44, 1998

Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method. Diagnostic Microbiology and Infectious Disease 71(3): 252-259, 2012

Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-a broth microdilution method for fluconazole susceptibility testing of Candida species. Journal of Clinical Microbiology 40(8): 2953-2958, 2002

Comparative analysis of the Vitek 2 antifungal susceptibility system and E-test with the CLSI M27-A3 broth microdilution method for susceptibility testing of Indian clinical isolates of Cryptococcus neoformans. Mycopathologia 173(5-6): 427-433, 2012

Comparative evaluation of FUNGITEST and broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans. Journal of Clinical Microbiology 36(4): 926-930, 1998

Correlation of Etest and Neo-Sensitabs diffusion assays on Mueller-Hinton-methylene blue agar with broth microdilution reference method (CLSI-M27-A2) for testing susceptibilities of Cryptococcus neoformans to amphotericin B and fluconazole. Medical Mycology 48(6): 893-896, 2010

Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp. Journal of Clinical Microbiology 45(3): 796-802, 2007

Susceptibility testing of cryptococcus neoformans employing a broth microdilution technique. Program & Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 32: 377, 1992

Comparative analysis of Etest and broth microdilution method (AFST-EUCAST) for trends in antifungal drug susceptibility testing of Brazilian Cryptococcus neoformans isolates. Journal of Medical Microbiology 55(Pt 12): 1693-1699, 2006

Comparative evaluation of FungitestReg., Neo-SensitabsReg. and M27T-NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans. Mycoses 42(4): 231-237, 1999

Comparative evaluation of Fungitest-, Neo-Sensitabs- and M27T-NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans. Mycoses 42(4): 231-237, 1999

Comparison of Etests and Vitek 2 ® to broth microdilution for the susceptibility testing of Cryptococcus neoformans. Diagnostic Microbiology and Infectious Disease 80(4): 294-298, 2015